BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4542454)

  • 21. [Blood type of thrombocytes and leukocytes--with reference to recent findings of homologous antibody].
    Yasunaga K
    Rinsho Byori; 1967; ():Suppl 14:39-49. PubMed ID: 4874329
    [No Abstract]   [Full Text] [Related]  

  • 22. Leukocyte antibodies and biologically active mediators in the pathogenesis of transfusion-related acute lung injury.
    Kopko PM
    Curr Hematol Rep; 2004 Nov; 3(6):456-61. PubMed ID: 15496281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonhemolytic transfusion reactions: reducing the incidence with leukocyte-poor red blood cells.
    Lichtiger B; Osier LE
    South Med J; 1983 Mar; 76(3):419. PubMed ID: 6828921
    [No Abstract]   [Full Text] [Related]  

  • 24. Responsiveness to HL-A as studied by monitoring blood transfusions and kidney transplants.
    Opelz G; Mickey MR; Terasaki PI
    Proc Eur Dial Transplant Assoc; 1973; 10(0):471-4. PubMed ID: 4607029
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-HLA white cell antibodies in nonhemolytic transfusion reactions.
    Matsuyama N; Hirayama F; Yasui K; Kojima Y; Furuta RA; Kimura T; Taniue A; Fukumori Y; Tani Y; Shibata H
    Transfusion; 2008 Jul; 48(7):1526-8. PubMed ID: 18651914
    [No Abstract]   [Full Text] [Related]  

  • 26. HL-A in connection with blood transfusion.
    Engelfriet CP; van Loghem JJ
    Haematologia (Budap); 1974; 8(1-4):267-72. PubMed ID: 4618231
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunology of posttransfusion complications].
    Shabalin VN; Serova LD
    Vestn Khir Im I I Grek; 1982 Oct; 129(10):89-94. PubMed ID: 7179672
    [No Abstract]   [Full Text] [Related]  

  • 28. [Post-transfusion reaction in women sensitized by leukocytic antigens].
    Vasil'eva ZF; Kuznechikova VV; Matveeva OF
    Probl Gematol Pereliv Krovi; 1970 May; 15(5):14-7. PubMed ID: 5431784
    [No Abstract]   [Full Text] [Related]  

  • 29. [Appearance of plaque-forming cells after transfusion].
    Baenkler HW; Decker R
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1810-1. PubMed ID: 5140926
    [No Abstract]   [Full Text] [Related]  

  • 30. [Leucocyte incompatibility as a cause of febrile transfusion reactions].
    Borchgrevink B
    Tidsskr Nor Laegeforen; 1966 Nov; 86(22):1538-41. PubMed ID: 5979059
    [No Abstract]   [Full Text] [Related]  

  • 31. [Selected cases of appearance of anti-HL-A antibodies in pregnant women].
    Zdebski Z; Bryniak C; Turowski G; Turowska B
    Przegl Lek; 1972; 29(9):832-5. PubMed ID: 5085120
    [No Abstract]   [Full Text] [Related]  

  • 32. A prospective study on the use of leucocyte-filters in reducing blood transfusion reactions in multi-transfused thalassemic children.
    Tan KK; Lee WS; Liaw LC; Oh A
    Singapore Med J; 1993 Apr; 34(2):109-11. PubMed ID: 8266145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Febrile transfusion reactions despite compatible cross matches.
    Hooper AD
    J Ky Med Assoc; 1977 Oct; 75(10):486-8. PubMed ID: 908880
    [No Abstract]   [Full Text] [Related]  

  • 34. Posttransfusion pulmonary edema.
    Moore SB; Popovsky MA
    Transplantation; 1983 Jun; 35(6):637-8. PubMed ID: 6868123
    [No Abstract]   [Full Text] [Related]  

  • 35. Transfusion of platelets and leukocytes. Associated problems.
    Cohen E
    N Y State J Med; 1971 Jun; 71(12):1522-5. PubMed ID: 5280723
    [No Abstract]   [Full Text] [Related]  

  • 36. Febrile transfusion reaction: what to do next?
    Tien SL
    Singapore Med J; 1993 Apr; 34(2):105-6. PubMed ID: 8266143
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic factors in reactions to blood transfusions.
    McLeod BC
    Heart Lung; 1980; 9(4):675-81. PubMed ID: 6773907
    [No Abstract]   [Full Text] [Related]  

  • 38. Interdisciplinary session report. Obstacles to routine transfusion support of myelosuppressive patients.
    Henderson ES; Graw RG; Anderson RM; Yankee RA; Opelz G; Lalezari P; Meryman HT
    Cancer Chemother Rep 3; 1973 May; 4(3):51-9. PubMed ID: 4748873
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complications in blood transfusion].
    Höglund S
    Lakartidningen; 1972 Dec; 69():Suppl 4:65-72. PubMed ID: 4656852
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
    Takano S; Omata M; Ohto M; Satomura Y
    Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.